Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

April 24, 2025

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

June 18, 2024

May 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

May 01, 2024

February 2022 News Roundup

News Opinion CV Team Dispatch

February 2022 News Roundup

February 01, 2022

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

April 22, 2021

AHA Seeks to Drive Down Amputations 20% by 2030

News Daily News

AHA Seeks to Drive Down Amputations 20% by 2030

April 01, 2021

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

December 24, 2020

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

August 12, 2020

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

News Features

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

May 01, 2019

Burden of Readmission High in PAD Patients Following Revascularization

News Daily News

Burden of Readmission High in PAD Patients Following Revascularization

December 04, 2017

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

November 06, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.